Pharmaceutical group · United States
Amneal
A group of 7 companies with 67 medicines in 3 countries.
Group structure
7 companies in 3 countries
Loading your page…
Loading your page…
Pharmaceutical group · United States
A group of 7 companies with 67 medicines in 3 countries.
7 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 67
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACEBUTOLOL HYDROCHLORIDE200mg base | 400mg base · Capsule | Acebutolol | United States | Marketed | 1995 |
| ACTIVELLA0.5MG; 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG; 0.5MG | 1MG/0.5MG · Tablet | Estradiol, Norethindrone | United States | Marketed | 1998 |
| ALBUTEROL SULFATE2mg base | 4mg base · Tablet | Salbutamol | United States | Marketed | 1989 |
| ALYMSYS100mg/4ml(25mg/ml | 400mg/16ml(25mg/ml · Injectable | Bevacizumab | United States | Marketed | 2022 |
| AMINOCAPROIC ACID1gm | 500mg · Tablet | Aminocaproic acid | United States | Marketed | 2018 |
| AMLODIPINE BENZOATE1mg base/ml · Suspension | Amlodipine benzoate | United States | Not marketed | 2023 |
| ARIPIPRAZOLE1mg/ml · Solution | Aripiprazole | United States | Marketed | 2015 |
| ATROPINE SULFATE1% · Solution/drops | Atropine | United States | Marketed | 2014 |
| BECLOMETHASONE DIPROPIONATE0.04mg/inh | 0.08mg/inh · Aerosol, metered | Beclometasone | United States | Marketed | 2025 |
| BEXAROTENE1% · GEL | Bexarotene | United States | Marketed | 2022 |
| BONCRESA60mg/ml · Injectable | Denosumab | United States | Marketed | 2025 |
| BREKIYA (AUTOINJECTOR)1mg/ml · Solution | Dihydroergotamine | United States | Marketed | 2025 |
| CALCIUM ACETATE667mg · Capsule | Calcium acetate | United States | Marketed | 2008 |
| ELURYNG0.015mg/24hr; 0.12mg/24hr · Ring | Ethinyl estradiol, Etonogestrel | United States | Marketed | 2019 |
| ERYTHROMYCIN250mg | 333mg | 500mg · Tablet, delayed release | Erythromycin | United States | Marketed | 2019 |
| ESTRADIOL10mcg · Tablet | Estradiol | United States | Marketed | 2015 |
| ESTRADIOL AND PROGESTERONE1mg; 100mg · Capsule | Estradiol, Progesterone | United States | Not marketed | 2022 |
| ETODOLAC400mg | 500mg · Tablet | Etodolac | United States | Marketed | 1997 |
| EXENATIDE SYNTHETIC300mcg/1.2ml (250mcg/ml) | 600mcg/2.4ml (250mcg/ml) · Injectable | Exenatide synthetic | United States | Marketed | 2024 |
| IBUPROFEN200mg | 200mg free acid and potassium salt · Capsule | Ibuprofen, Salt | United States | Marketed | 1998 |
| IOHEXOL64.7% · Solution | Iohexol | United States | Marketed | 2025 |
| KITPROZY120mg/2ml (60mg/ml), 2ml | 60mg/ml, 2/ml · Vial | Carfilzomib | United States | Marketed | 2026 |
| LIORESAL0.05mg/ml | 0.5mg/ml | 2mg/ml · Injectable | Baclofen | United States | Marketed | 1992 |
| LISDEXAMFETAMINE DIMESYLATE10mg | 20mg | 30mg | 40mg | 50mg | 60mg | 70mg · Capsule | Lisdexamfetamine dimesylate | United States | Marketed | 2023 |
| LOTEPREDNOL ETABONATE0.2% | 0.5% · Suspension/drops | Loteprednol | United States | Marketed | 2019 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 62 | 59 | 3 | CompaniesAll medicines |
| Spain | 4 | 1 | 3 | CompaniesAll medicines |
| European Union (EMA) | 1 | 0 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.